Introduction {#s0005}
============

Oxidants, including superoxide radicals and hydrogen peroxide, are continuously produced intracellularly as byproducts of energetic metabolism [@bib1; @bib2; @bib3]. These oxidants have been increasingly recognized as participants in both signaling and damaging processes [@bib4; @bib5; @bib6; @bib7]. Indeed, dietary habits and pathological conditions are closely associated with changes in oxidant production rates, types of oxidants generated and their levels within different tissues, resulting in changes in oxidative modifications to biomolecules that may lead to cell damage and disease [@bib7; @bib8; @bib9; @bib10; @bib11].

Mitochondria are recognized as the most quantitatively relevant source of oxidants in most cells, and are particularly important when considering oxidants produced as a result of energetic metabolism [@bib7; @bib12; @bib13; @bib14]. Mitochondrial oxidant production and release is highly variable depending on the tissue, age, diet and antioxidant status and is regulated by respiratory state and substrates, among other characteristics [@bib7; @bib12; @bib13; @bib14]. This production of mitochondrial oxidants is most often ascribed to the electron transport chain, in which monoelectronic reduction of oxygen may occur at the levels of complexes I, II and III, generating superoxide radicals and other oxidants derived from it. However, more recent work has demonstrated that other sources of mitochondrial oxidants not only exist, but are quantitatively sizable. These alternative mitochondrial oxidant sources include the monoaminoxidase, α-ketoglutarate dehydrogenase and glycerol phosphate dehydrogenase [@bib7; @bib13; @bib15].

Recently, using a diet-induced steatosis model, we demonstrated that high fat ingestion strongly increases liver mitochondrial H~2~O~2~ release supported by activated fatty acids [@bib16]. Experiments modulating electron transport chain activity suggested that the production of H~2~O~2~ did not involve the generation of superoxide radicals at the level of the respiratory chain, but rather occurred in a manner dependent only on fatty-acid oxidation pathways. Based on these results, and the comparison of the effects of different sizes of fatty acids, we suggested that the production of H~2~O~2~ observed stemmed from flavoproteins involved in the metabolism of very long chain acyl-CoAs. Here, we study the regulation of fatty-acid-supported H~2~O~2~ release from mitochondria and provide direct evidence that the very long chain acyl-CoA dehydrogenase, a component of the β-oxidation pathway, has a residual oxidase activity, generating H~2~O~2~ within mitochondria.

Materials and methods {#s0010}
=====================

Animals and diet {#s0015}
----------------

Experiments involving isolated mitochondria were performed with samples prepared from 6 weeks old female Swiss mice. During 1 week prior to the experiment, control and high fat diet (HFD) mice were fed with standard diets, but the water source of the HFD group was supplemented with soy oil (30% v/v) in emulsion with 9 g L^−1^ sodium stearoyl lactylate [@bib16]. All experiments were approved by the local animal care and use committee (*Comissão de Ética no Uso de Animais*) which is overseen by the National committee on research animal use (*Conselho Nacional de Controle de Experimentação Animal -- CONCEA*) and has standards compatible with the NIH Guide for the Care and Use of Laboratory Animals.

Mitochondrial isolation {#s0020}
-----------------------

Mice were sacrificed by cervical dislocation and the livers were placed in cold isolation buffer containing 300 mM sucrose, 1 mM EGTA, 10 mM HEPES and 0.1% BSA, pH 7.2. The tissue was minced with surgical scissors and then extracts were obtained using a potter homogenizer. The extract was centrifuged at 4 °C for 5 min at 600*g*. The supernatant was then centrifuged at 4 °C for 5 min at 12,000*g*. The remaining pellet, containing mitochondria, was resuspended in the same buffer [@bib17]. To promote membrane permeabilization, samples were frozen at −20 °C and then thawed just prior to the experiments.

Hydrogen peroxide generation {#s0025}
----------------------------

H~2~O~2~ generation was monitored fluorimetrically by following the oxidation of Amplex Red to resorufin, at 37 °C, ex=563 nm and em=595 nm. Mitochondria permeabilized by freezing and thawing (0.2 mg mL^−1^) were incubated in experimental buffer (150 mM KCl, 2 mM MgCl~2~, 2 mM EGTA, 2 mM KH~2~PO~4~ and 10 mM HEPES, pH 7.4) in presence of 5 µM Amplex Red, 1 U mL^−1^ horseradish peroxidase (HRP), 50 µM palmitoyl-CoA and varying concentrations of AMP, ADP, ATP, GDP and GTP [@bib16]. For the pH assay, mitochondria were incubated in 100 mM KCl, 2 mM EGTA, 2 mM MgCl~2~, 50 µM palmitoyl-CoA, 2 mM KH~2~PO~4~, 10 mM acetate, 10 mM MES, 10 mM HEPES, 10 mM tricine, 10 mM TRIS, and 10 mM glycine, and the pH was adjusted from 4.5 to 10 using K^+^ and Cl^−^ salts. Purified VLCAD was incubated in phosphate buffer (100 mM KH~2~PO~4~, 0.1 mM EDTA, pH 7.2) at 37 °C for 45 min in presence of Amplex Red, HRP (as described above), and varying concentrations of palmitoil-CoA (0--400 µM). Calibration curves were constructed using known H~2~O~2~ concentrations for each pH in which measurements were made.

VLCAD (Δ*E*x3) expression in *Escherichia coli* and purification {#s0030}
----------------------------------------------------------------

The plasmid for the expression of human VLCAD was kindly donated by professors Jung-Ja Kim (Medical College of Wisconsin, Milwaukee, WI) and Jerry Vockley (University of Pittsburgh, Children\'s Hospital of Pittsburgh, Pittsburgh, PA). It consists of the human VLCAD sequence devoid of exon 3 by alternative splicing of the N-terminal region \[VLCAD (Δ*E*x3)\] inserted into a pET21a plasmid. pET21A-VLCAD (Δ*E*x3) was inserted by heat shock into competent XL1Blue *E. coli* (obtained by the CaCl~2~ method) and grown overnight at 37 °C. The expanded construct was then purified with the Promega Wizard® Plus SV Minipreps DNA Purification System and eluted in nuclease-free water. The VLCAD (Δ*E*x3) sequence was amplified by PCR, separated in an agarose gel and purified with the Promega Wizard® PCR Gel and PCR Clean Up kit. The purified PCR product was inserted in the pLATE51 plasmid using an *aLICator Thermo Scientific*® kit, which adds a 6× histidine tail at the N-terminal region. pLATE51-VLCAD (Δ*E*x3) was then inserted by heat shock into competent Nova Blue *E. coli* (also obtained by the CaCl~2~ method) and a pre-inoculum was prepared in Luria-Bertani (LB) medium containing 50 µg mL^−1^ ampicillin and grown overnight at 37 °C. Two hundred microliters were inoculated in fresh LB (200 mL) containing ampicillin (50 µg mL^−1^) and grown to an OD~600~ of 0.6--0.8. Isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG, 0.4 mM) was added and the culture was grown overnight at 20 °C. The culture was centrifuged (14,000*g*, 10 min) and the pellet was resuspended in lysis buffer (200 mM KH~2~PO~4~, 200 mM NaCl, 20 mM imidazole, 10% glycerol, pH 7.8) and sonicated (3 times, 15 s) over ice. The sample was centrifuged (14,000*g*, 10 min) and 200 µL of Ni-NTA Agarose resin were added, followed by 15 min incubation with agitation. The resin was washed five times with phosphate buffer (200 mM KH~2~PO~4~, 200 mM NaCl, 20 mM imidazole, pH 7.8) and VLCAD (Δ*E*x3) was eluted in phosphate buffer containing a higher concentration of imidazole (200 mM KH~2~PO~4~, 200 mM NaCl, 500 mM imidazole, pH 7.8) initial.

Western blotting {#s0035}
----------------

One milliliter of the culture was centrifuged (14,000*g*, 5 min). The pellets (induced or not) were resuspended in 200 and 100 µL, respectively, of sample buffer (4% glycerol, 10 mM dithiothreitol, 2% SDS, 0.05% bromophenol blue, 40 mM Tris--HCl, pH 6.8) and boiled for 5 min. Ten microliters of the purified enzyme were diluted in sample buffer and boiled for 5 min. Ten microliters of resuspended culture in sample buffer were then added to each well of an SDS-PAGE gel. After 1 h of separation at 200 V, the proteins were transferred to a membrane which was later developed using primary Santa Cruz® anti-VLCAD overnight and secondary anti-rabbit for 1 h. A second membrane was developed using primary Qiagen® HRP conjugated anti-PentaHis overnight. Both systems were visualized directly on the membrane with the BioRad® Opti-4CN Substrate kit.

VLCAD enzymatic activity {#s0040}
------------------------

The purified enzyme (0.7±0.3 µg) was incubated in phosphate buffer (100 mM KH~2~PO~4~ and 0.1 mM EDTA, pH 7.2) at 37 °C for 45 min in presence of 150 µM ferricenium hexafluorophosphate and palmitoyl-CoA at varying concentrations (0--1400 µM). For pH experiments, VLCAD and palmitoyl-CoA (200 µM) was incubated in buffer containing 2 mM KH~2~PO~4~, 10 mM acetate, 10 mM MES, 10 mM HEPES, 10 mM tricine, 10 mM TRIS, 10 mM glycine and 2 mM EGTA, and the pH was adjusted from 4.5 to 10. The decrease in absorbance of ferricenium due its reduction by VLCAD-linked FADH~2~ was accompanied at 300 nm. The molar extinction coefficient used was 4.3 mM cm^−1^ [@bib18].

Protein quantification {#s0045}
----------------------

Experiments were normalized by protein concentration using the Bio-Rad Bradford reagent protein assay and bovine serum albumin as standard. The absorbance was measured at 595 nm.

Statistics {#s0050}
----------

Data analysis was conducted using OriginLab and GraphPad Prism software using *T* tests and ANOVA*.* Data shown are averages±standard deviations of 3--6 experiments.

Results {#s0055}
=======

In a prior publication [@bib16], we demonstrated that a short-term (1 week) high fat diet resulted in largely increased H~2~O~2~ release in liver mitochondria energized by palmitoyl-CoA (palm-CoA), but not other substrates such as pyruvate or succinate. These results suggest that H~2~O~2~ was produced as a result of fatty acid oxidation, and not at the level of the mitochondrial electron transport chain. Indeed, as observed in [Fig. 1](#f0005){ref-type="fig"}A, we see a consistently increased mitochondrial H~2~O~2~ production in the presence of palm-CoA in liver mitochondria from animals fed a high fat diet (full bars) relative to animals on standard laboratory chow alone (open bars). These experiments were conducted in mitochondrial samples in which membrane integrity was disrupted by freeze--thawing, thus avoiding the accumulation of β-oxidation and reducing intermediates, again suggesting that H~2~O~2~ was being produced by reactions directly coupled to palm-CoA oxidation.

Given the large increase in oxidant release observed, we sought to uncover potential regulatory stimuli for high fat diet-stimulated, palm-CoA-induced, H~2~O~2~ release in mitochondria. Interestingly, we found out that, while high fat diet samples ([Fig. 1](#f0005){ref-type="fig"}A, full bars) consistently generated higher H~2~O~2~ levels, classical metabolic regulators AMP, ADP, ATP, GDP and GTP had no significant influence on this effect. On the other hand, palm-CoA-induced mitochondrial H~2~O~2~ release was strongly pH sensitive ([Fig. 1](#f0005){ref-type="fig"}B) in both control (open symbols) and high fat diet (closed symbols) samples. The peak of H~2~O~2~ release was observed at a pH of \~8.5, which is close to the physiological mitochondrial matrix pH (\~7.8 [@bib19; @bib20]), and suggests this H~2~O~2~ production may be sensitive to fluctuations in ATP synthesis, which is accompanied by mitochondrial matrix acidification.

H~2~O~2~ generation promoted by palm-CoA but independent of electron transport chain activity may occur at multiple points of mitochondrial fatty acid oxidation pathways. Most probable sources of oxidants are flavoenzymes, many of which have been previously demonstrated to be significant mitochondrial sources of oxidants [@bib7; @bib13; @bib15]. Indeed, we find that the short-term high fat diet used significantly increases the expression of many liver mitochondrial flavoenzymes involved in fatty acid oxidation, including various isoforms of acyl-CoA dehydrogenases and electron transferring flavoproteins [@bib16]. Experiments using different sizes of activated fatty acids as substrates suggested that the probable source of H~2~O~2~ under these conditions was the very long chain acyl CoA dehydrogenase (VLCAD).

Since the mitochondrial microenvironment is highly rich in electron-transferring enzymes, in order to directly verify if VLCAD can be, in itself, a source of mitochondrial oxidants, we decided to express the recombinant enzyme and study its redox activity ([Fig. 2](#f0010){ref-type="fig"}). Human VLCAD [@bib21] with a His tag was successfully expressed in *E. coli*, and could be detected with a molecular mass of \~74 kDa after induction using both anti-VLCAD ([Fig. 2](#f0010){ref-type="fig"}A, upper blot) or anti-His ([Fig. 2](#f0010){ref-type="fig"}A, lower blot). Purity was ensured by using an affinity column. The enzyme was also fully active, and presented a saturable, palm-CoA-dependent reducing activity ([Fig. 2](#f0010){ref-type="fig"}B and C). Furthermore, the activity of the enzyme was pH dependent, with a peak at \~7.9 ([Fig. 2](#f0010){ref-type="fig"}D).

Interestingly, the purified recombinant VLCAD generated detectable levels of H~2~O~2~ ([Fig. 3](#f0015){ref-type="fig"}A), in a manner dependent on the concentration of palm-CoA ([Fig. 3](#f0015){ref-type="fig"}B). Because these experiments were conducted in the absence of superoxide dismutase, the presence of detectable H~2~O~2~ release indicates that this oxidant is produced directly by VLCAD, acting as an oxidase. Comparisons between the dehydrogenase activity ([Fig. 2](#f0010){ref-type="fig"}) and oxidase activity ([Fig. 3](#f0015){ref-type="fig"}) indicate that between 3.5% and 5.7% of electrons derived from palm-CoA by VLCAD are destined to the oxidase activity.

Discussion {#s0060}
==========

Mitochondrially-originated oxidants, including H~2~O~2~, are implicated in the pathology and progression of a variety of conditions, including metabolic diseases. Specifically in the liver, mitochondrially-generated oxidants may contribute to the development of both non-alcoholic and alcoholic steatohepatosis, cytolytic hepatitis, cirrhosis and hepatocarcinoma [@bib22; @bib23]. Indeed, we have previously found that non-alcoholic steatohepatosis induced by a short-term high fat diet leads to increases in tissue oxidative damage markers associated with increased mitochondrial H~2~O~2~ release [@bib16]. Since these increased H~2~O~2~ levels were only observed in the presence of palm-CoA, were not dependent on mitochondrial respiration and were inhibited by increasing concentrations of NAD^+^, we hypothesized that the production of this oxidant occurred upstream of the respiratory chain, most probably at the level of VLCAD.

Here, by using recombinant, purified, human VLCAD, we provide unequivocal evidence that this enzyme can, indeed, generate H~2~O~2~ directly, in a manner stimulated by its substrate and electron donor, palm-CoA. Since H~2~O~2~ could be detected in the absence of added superoxide dismutase, these data also show that VLCAD generates H~2~O~2,~ and not superoxide radicals, primarily. VLCAD is thus acting as an acyl-CoA oxidase. The oxidase activity of VLCAD is partial, comprising less than 6% of its maximal activity under our experimental conditions, an expected result since the primary metabolic function of this enzyme within β-oxidation is to act as a dehydrogenase. However, although partial, this oxidase activity is continuous and thus expected to have quite a sizable overall contribution, particularly under conditions, such as high fat diets, in which the expression of VLCAD increases significantly [@bib16].

VLCAD thus joins a growing family of mitochondrial enzymes capable of generating detectable quantities of oxidants under biologically relevant conditions, including electron transfer chain components (Complexes I, II and III), pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, glycerol phosphate dehydrogenase, electron transfer flavoprotein (ETF) and ETF-oxidoreductase and monoamine oxidase [@bib1; @bib7; @bib10; @bib12; @bib13; @bib14]. Overall, our data and that from other laboratories indicate that mitochondrial sources of oxidants are numerous, not restricted to the electron transport chain and present variable regulatory characteristics. In particular, mitochondrial flavoenzymes have been increasingly recognized as intracellular sources of oxidants. Many of these flavoenzymes (including pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, glycerol phosphate, ETF and ETF-oxidoreductase) appear to generate superoxide radicals as the primary oxidant. Superoxide radicals are then efficiently converted to H~2~O~2~ due to the abundance of superoxide dismutase in mitochondria [@bib7]. On the other hand, we find that VLCAD, similarly to the monoamine oxidase [@bib1; @bib24; @bib25], generates H~2~O~2~ directly.

The partial oxidase activity of VLCAD measured here may be justified by its structural characteristics. All mitochondrial acyl-CoA dehydrogenases present structural similarities to peroxisomal acyl-CoA oxidases [@bib26], but are able to exclude oxygen from the catalytic site, thus maintaining a primary dehydrogenase activity. VLCAD, predictably, has the largest hydrophobic substrate binging cavity of the acyl-CoA dehydrogenases [@bib27], a characteristic which may facilitate a partial oxidase activity. Indeed, when structural characteristics are compared side-by-side, the main difference between oxidases and their corresponding dehydrogenases is the shielding of the FAD from the solvent in dehydrogenases [@bib28]. This shielding is expected to be more difficult to achieve in VLCAD due to the size of the substrate side chain, thus making this enzyme the acyl-CoA dehydrogenase most prone to act as a partial oxidase.

Overall, our data show that VLCAD is a sizable source of H~2~O~2~ in mitochondria, capable of generating this oxidant in the nmol min^−1^ mg^−1^ protein range, in a manner sensitive to matrix pH (therefore stimulated by conditions of low oxidative phosphorylation) and very significantly stimulated by high fat diets. The understanding of the mechanisms leading to the production of this oxidant are particularly important given the prevalence of high fat diets in modern society and the large impact on liver mitochondrial H~2~O~2~ release, even when these diets are adopted short-term.
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![Palm-CoA-induced H~2~O~2~ release is modulated by diet and pH, but not purine nucleotides. H~2~O~2~ release from freeze-permeabilized mitochondria was measured in using 5 µM Amplex Red and 1 U mL^−1^ HRP. Panel A: H~2~O~2~ release in the presence of varying AMP, ADP, ATP, GDP or GTP concentrations, as indicated; *n*=4. Panel B: H~2~O~2~ release was measured at varying pH, as indicated. The detection was calibrated separately with known H~2~O~2~ concentrations for each pH. *n*=6 per group.](gr1){#f0005}

![Expression and purification of active VLCAD (Δ*E*x3). Panel A: Western blot of Nova blue *E. coli*. The upper blot was developed using Santa Cruz® anti-VLCAD; the lower blot with Qiagen® anti-PentaHis. "Purified" refers to the eluted enzyme in phosphate buffer (pH 7.8), and "induced" refers to cultures incubated with 0.4 mM IPTG. Panels B and C: the activity of the purified recombinant VLCAD (Δ*E*x3) was measured as described in [@bib18] in phosphate buffer, pH 7.2, at 37 °C, for 30 min, in presence of 150 µM hexafluorophosphate ferricenium and varying concentrations of palm-CoA (100--1500 µM). Panel D: The activity of the purified recombinant VLCAD (Δ*E*x3) was measured as described in [@bib18] in the buffer described in Section Materials and methods adjusted to the range of pH shown in presence of 150 µM hexafluorophosphate ferricenium and 200 µM palm-CoA.](gr2){#f0010}

![H~2~O~2~ generation by purified VLCAD (Δ*E*x3). Panel A: H~2~O~2~ was detected using 5 µM Amplex Red and 1 U mL^−1^ HRP in phosphate buffer, pH 7.2, containing purified recombinant VLCAD in the presence of 400 µM palm-CoA, at 37 °C, for 30 min; ^⁎^*p*\<0.001 relative to buffer; \#*p*\<0.001 relative to VLCAD. Panel B: H~2~O~2~ release measured under the conditions of Panel A in the presence of varying palm-CoA concentrations (0--400 µM).](gr3){#f0015}
